Predicting which HIV patients may stop attending care
Clinical Phenotyping for Prediction of Retention in HIV Care
['FUNDING_R21'] · UNIVERSITY OF CHICAGO · NIH-10762595
This study is looking at ways to help people with HIV stay connected to their healthcare by figuring out who might need extra support to keep coming back for their appointments.
Quick facts
| Phase | ['FUNDING_R21'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF CHICAGO (nih funded) |
| Locations | 1 site (CHICAGO, UNITED STATES) |
| Trial ID | NIH-10762595 on ClinicalTrials.gov |
What this research studies
This research focuses on improving the retention of patients in HIV care by developing a predictive model that identifies individuals at risk of losing follow-up. By analyzing electronic health data and using natural language processing on provider notes, the study aims to quantify a patient's risk of disengagement from care based on their unique characteristics. The goal is to assist healthcare teams in targeting resources effectively before patients fall out of care, ultimately enhancing treatment outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals living with HIV who are currently receiving care but may be at risk of losing follow-up.
Not a fit: Patients who are not currently engaged in HIV care or those who are not at risk of losing follow-up may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved retention rates in HIV care, helping patients maintain their treatment and health.
How similar studies have performed: Preliminary data from similar approaches using machine learning and natural language processing have shown promise in predicting patient retention in care.
Where this research is happening
CHICAGO, UNITED STATES
- UNIVERSITY OF CHICAGO — CHICAGO, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: RIDGWAY, JESSICA — UNIVERSITY OF CHICAGO
- Study coordinator: RIDGWAY, JESSICA
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Acquired Immune Deficiency Syndrome Virus